GlassScriptPhysician profile
Cheryl Renee Branch
NPI 1205814753
$12,127.88
in general payments reported to CMS, 2019-2025
49 companies · $1,168 in 2025
The $1,168 reported for 2025 was more than what 88% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,699 · 2020: $2,170 · 2021: $2,340 · 2022: $1,557 · 2023: $1,219 · 2024: $974 · 2025: $1,168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,361.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,361.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,831.76 | 2019-2025 | Repatha, Evenity, Otezla |
| Abbvie INC. | $1,763.95 | 2019-2025 | Vraylar, Ubrelvy, Linzess |
| Novo Nordisk INC | $1,092.56 | 2019-2025 | Wegovy |
| Pfizer INC. | $972.64 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $890.48 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $758.69 | 2019-2023 | Verquvo, Belsomra, Steglatro |
| Astrazeneca Pharmaceuticals LP | $561.83 | 2019-2025 | Farxiga, Airsupra |
| Esperion Therapeutics, INC. | $359.00 | 2020-2022 | |
| Astellas Pharma US INC | $318.55 | 2019-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $295.62 | 2021-2025 | |
| Lilly USA, LLC | $279.69 | 2019-2023 | Mounjaro, Jardiance, Trulicity |
| Janssen Pharmaceuticals, INC | $257.40 | 2019-2022 | |
| Amarin Pharma, INC. | $245.85 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $208.54 | 2020-2022 | |
| Allergan, INC. | $197.98 | 2019-2020 |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheryl Branch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.